HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Valerie Bastiaens Selected Research

Breast Neoplasms (Breast Cancer)

2/2018Subcutaneous trastuzumab (Herceptin) versus intravenous trastuzumab for the treatment of patients with HER2-positive breast cancer: A time, motion and cost assessment study in a lean operating day care oncology unit.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Valerie Bastiaens Research Topics

Disease

1Breast Neoplasms (Breast Cancer)
02/2018

Drug/Important Bio-Agent (IBA)

1Trastuzumab (Herceptin)FDA Link
02/2018

Therapy/Procedure

1Medical Day Care (Partial Hospitalization)
02/2018